Found 0 matching trials
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors PHASE2 We conducted a single-center, prospective randomized ,Parallel controls, op...
Show More Learn More & Join Trial
Viscum Album for TNBC on Adjuvant Pembrolizumab PHASE4 The goal of this clinical trial is to evaluate the efficacy and safety of V...
Show More Location
Ilsan Cha Hospital
Learn More & Join Trial
A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors PHASE1 The purpose of this study is to assess the safety and tolerability of ASP98...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors PHASE1 GSK1795091 is being developed for administration in combination with other ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer PHASE1 The term of biliary tract cancer (BTC) or cholangiocarcinoma refers to all ...
Show More Location
Severance Hospital
Learn More & Join Trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer PHASE2 The purpose of this study is to further advance the ability to practice per...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver Transplant NA Objectives of Study:This study will evaluate the safety and efficacy of pem...
Show More Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Learn More & Join Trial
Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer PHASE2 The standard treatment for women with stage I, II, and III triple-negative ...
Show More Location
The University of Kansas Cancer Center (KUCC)
Learn More & Join Trial
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) PHASE1 In this study, participants with different types of advanced solid tumors w...
Show More Location
Sun Yat-sen University Cancer Center (SYSUCC)
Learn More & Join Trial
A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003) PHASE2 The purpose of this study is to evaluate the safety, tolerability and objec...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial